Menu Search
Equities

BioQuest Corp

  • Add to watchlist
  • Add to portfolio
  • Add an alert
BQST:PKC

BioQuest Corp

Actions
  • Price (USD)0.5110
  • Today's Change0.00 / 0.00%
  • Shares traded1.25k
  • 1 Year change-51.33%
  • Beta--
Data delayed at least 15 minutes, as of Nov 20 2025 15:05 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

BioQuest Corp. is a conversational artificial intelligence (AI) technology company. The Company, through BotMakers, Inc., specializes in the development of advanced conversational AI systems for businesses, enabling them to streamline customer interactions, increase efficiency, and enhance service offerings. It employs AI Agents for lead engagement, qualification and sales, CRM automation, and voice interaction systems, and Ai solutions for clinical communications. It is expanding its AI platform and its offerings into biotech, healthcare and B2B sectors.

  • Revenue in USD (TTM)0.00
  • Net income in USD-507.41k
  • Incorporated2011
  • Employees--
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status		BQST:PKC since
announced		Transaction
value
BotMakers IncDeal completed19 Mar 202519 Mar 2025Deal completed-49.41%--
Data delayed at least 15 minutes, as of Nov 20 2025 15:05 GMT.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.